We celebrated this morning the opening of the new Singapore #TechCenter of the Fedegari Group, world leader in innovative solutions for clean and sterile processes in the #biomedical sector. The post-Covid evolution of #DrugManufacturing now requires a less conventional approach and a new vision in delivering human-less manufacturing solutions for advanced sterile products. Fedegari is an example of Italian excellence that brings cutting-edge technology to the sector and that will be able to address the whole of South-East Asia from the #Singapore Hub. #Pharmaceutical production in Italy is growing strongly. Over 50 billion in 2023 of which about 90% for export. The growth in production is accompanied by the extraordinary scientific and technological acceleration that we are experiencing. Artificial intelligence, data driven industry, high tech equipments, research in space, new models of clinical trials, new frontiers of R&D increasingly allow the personalization of therapies.
-
-
-
-
-
+1